Here are three quick points:
1. The technology embeds zinc-oxide nanoparticles onto any readymade fabric, thereby converting it into an antibacterial textile.
2. These antibacterial fabrics can help mitigate the spread of hospital-acquired infections and minimize cross contamination between patients and medical staff.
3. The technology has been patented in the United States and Israel, and it is awaiting approval in Europe and Asia.
More articles on ASC quality:
3 US infants born with Zika-related defects: 4 takeaways
If contracted late, Zika virus may not cause microcephaly in infants — 5 points
Legislators voice concern over ‘unstoppable superbug’ making its way into US: 5 notes
